Mirae Asset Global Investments Co. Ltd. Has $2.93 Million Holdings in Mettler-Toledo International, Inc. (NYSE:MTD)

Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 13.3% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,488 shares of the medical instruments supplier's stock after purchasing an additional 292 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Mettler-Toledo International were worth $2,929,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Farther Finance Advisors LLC increased its position in shares of Mettler-Toledo International by 14.3% during the fourth quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock worth $78,000 after acquiring an additional 8 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its stake in Mettler-Toledo International by 3.0% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier's stock worth $374,000 after purchasing an additional 9 shares during the period. Atlantic Union Bankshares Corp boosted its stake in Mettler-Toledo International by 0.5% in the 4th quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier's stock worth $2,549,000 after purchasing an additional 10 shares during the period. Sequoia Financial Advisors LLC increased its holdings in Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares in the last quarter. Finally, Congress Asset Management Co. raised its stake in shares of Mettler-Toledo International by 1.8% in the 1st quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock valued at $788,000 after purchasing an additional 12 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Mettler-Toledo International

In related news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director directly owned 120 shares of the company's stock, valued at approximately $139,191.60. The trade was a 89.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.94% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on MTD. Barclays initiated coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective for the company. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their price target for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price for the company in a report on Monday, April 7th. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $1,300.36.

Mettler-Toledo International Stock Up 0.3%

Shares of NYSE MTD traded up $3.43 during trading hours on Friday, hitting $1,209.08. The company had a trading volume of 41,859 shares, compared to its average volume of 150,220. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,546.93. The firm's 50 day moving average is $1,147.91 and its 200-day moving average is $1,196.27. The stock has a market capitalization of $25.13 billion, a P/E ratio of 30.15, a price-to-earnings-growth ratio of 3.71 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The firm had revenue of $883.74 million during the quarter, compared to analysts' expectations of $876.61 million. During the same quarter last year, the company posted $8.89 earnings per share. The company's revenue for the quarter was down 4.6% compared to the same quarter last year. On average, sell-side analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.